Literature DB >> 25230669

GATM gene variants and statin myopathy risk.

D F Carr1, A Alfirevic1, R Johnson1, H Chinoy2, T van Staa3, M Pirmohamed1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25230669     DOI： 10.1038/nature13628

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  4 in total

1.  SLCO1B1 variants and statin-induced myopathy--a genomewide study.

Authors:  E Link; S Parish; J Armitage; L Bowman; S Heath; F Matsuda; I Gut; M Lathrop; R Collins
Journal:  N Engl J Med       Date:  2008-07-23       Impact factor: 91.245

2.  A statin-dependent QTL for GATM expression is associated with statin-induced myopathy.

Authors:  Lara M Mangravite; Barbara E Engelhardt; Marisa W Medina; Joshua D Smith; Christopher D Brown; Daniel I Chasman; Brigham H Mecham; Bryan Howie; Heejung Shim; Devesh Naidoo; QiPing Feng; Mark J Rieder; Yii-Der I Chen; Jerome I Rotter; Paul M Ridker; Jemma C Hopewell; Sarah Parish; Jane Armitage; Rory Collins; Russell A Wilke; Deborah A Nickerson; Matthew Stephens; Ronald M Krauss
Journal:  Nature       Date:  2013-08-28       Impact factor: 49.962

3.  SLCO1B1 genetic variant associated with statin-induced myopathy: a proof-of-concept study using the clinical practice research datalink.

Authors:  D F Carr; H O'Meara; A L Jorgensen; J Campbell; M Hobbs; G McCann; T van Staa; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2013-08-13       Impact factor: 6.875

4.  Electronic health records for biological sample collection: feasibility study of statin-induced myopathy using the Clinical Practice Research Datalink.

Authors:  Helen O'Meara; Daniel F Carr; Jane Evely; Mark Hobbs; Gerard McCann; Tjeerd van Staa; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335
  4 in total
  16 in total

1.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

2.  Mangravite et al. reply.

Authors:  Lara M Mangravite; Barbara E Engelhardt; Matthew Stephens; Ronald M Krauss
Journal:  Nature       Date:  2014-09-18       Impact factor: 49.962

3.  Correlation between single-nucleotide polymorphisms and statin-induced myopathy: a mixed-effects model meta-analysis.

Authors:  Qian Xiang; Xiao-Dan Zhang; Guang-Yan Mu; Zhe Wang; Zhi-Yan Liu; Qiu-Fen Xie; Kun Hu; Zhuo Zhang; Ling-Yue Ma; Jie Jiang; Yi-Min Cui
Journal:  Eur J Clin Pharmacol       Date:  2020-11-04       Impact factor: 2.953

4.  GATM polymorphism associated with the risk for statin-induced myopathy does not replicate in case-control analysis of 715 dyslipidemic individuals.

Authors:  Jasmine A Luzum; Joseph P Kitzmiller; Paul J Isackson; Changxing Ma; Marisa W Medina; Anees M Dauki; Eduard B Mikulik; Heather M Ochs-Balcom; Georgirene D Vladutiu
Journal:  Cell Metab       Date:  2015-04-07       Impact factor: 27.287

Review 5.  Treatment Options for Statin-Associated Muscle Symptoms.

Authors:  Ulrich Laufs; Hubert Scharnagl; Martin Halle; Eberhard Windler; Matthias Endres; Winfried März
Journal:  Dtsch Arztebl Int       Date:  2015-10-30       Impact factor: 5.594

Review 6.  Identifying genetic modulators of statin response using subject-derived lymphoblastoid cell lines.

Authors:  Yu-Lin Kuang; Elizabeth Theusch; Ronald M Krauss; Marisa W Medina
Journal:  Pharmacogenomics       Date:  2021-04-16       Impact factor: 2.533

Review 7.  Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.

Authors:  Erik S Stroes; Paul D Thompson; Alberto Corsini; Georgirene D Vladutiu; Frederick J Raal; Kausik K Ray; Michael Roden; Evan Stein; Lale Tokgözoğlu; Børge G Nordestgaard; Eric Bruckert; Guy De Backer; Ronald M Krauss; Ulrich Laufs; Raul D Santos; Robert A Hegele; G Kees Hovingh; Lawrence A Leiter; Francois Mach; Winfried März; Connie B Newman; Olov Wiklund; Terry A Jacobson; Alberico L Catapano; M John Chapman; Henry N Ginsberg
Journal:  Eur Heart J       Date:  2015-02-18       Impact factor: 29.983

8.  Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.

Authors:  Marshall B Elam; Gipsy Majumdar; Khyobeni Mozhui; Ivan C Gerling; Santiago R Vera; Hannah Fish-Trotter; Robert W Williams; Richard D Childress; Rajendra Raghow
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

9.  Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing.

Authors:  James S Floyd; Katarzyna M Bloch; Jennifer A Brody; Cyrielle Maroteau; Moneeza K Siddiqui; Richard Gregory; Daniel F Carr; Mariam Molokhia; Xiaoming Liu; Joshua C Bis; Ammar Ahmed; Xuan Liu; Pär Hallberg; Qun-Ying Yue; Patrik K E Magnusson; Diane Brisson; Kerri L Wiggins; Alanna C Morrison; Etienne Khoury; Paul McKeigue; Bruno H Stricker; Maryse Lapeyre-Mestre; Susan R Heckbert; Arlene M Gallagher; Hector Chinoy; Richard A Gibbs; Emmanuelle Bondon-Guitton; Russell Tracy; Eric Boerwinkle; Daniel Gaudet; Anita Conforti; Tjeerd van Staa; Colleen M Sitlani; Kenneth M Rice; Anke-Hilse Maitland-van der Zee; Mia Wadelius; Andrew P Morris; Munir Pirmohamed; Colin A N Palmer; Bruce M Psaty; Ana Alfirevic
Journal:  PLoS One       Date:  2019-06-26       Impact factor: 3.240

Review 10.  Pharmacogenomics of statins: understanding susceptibility to adverse effects.

Authors:  Joseph P Kitzmiller; Eduard B Mikulik; Anees M Dauki; Chandrama Murkherjee; Jasmine A Luzum
Journal:  Pharmgenomics Pers Med       Date:  2016-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.